IBM and the New York Genome Center will collaborate on a comprehensive and open repository of genetic data to accelerate cancer research, using Watson technology. The collaboration was announced at the White House’s Precision Medicine Initiative Summit. IBM and the center will build the capacity to house the contributed data, train Watson’s cognitive computing capabilities...
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe